New developments in aetiological mechanisms of inflammatory bowel disease

被引:11
|
作者
Schölmerich, J [1 ]
机构
[1] Univ Regensburg, Dept Internal Med 1, D-93042 Regensburg, Germany
关键词
ulcerative colitis; Crohn's disease; inflammatory bowel disease; aetiology; genetics; bacteria;
D O I
10.1097/01.meg.0000059149.68845.17
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This review in depth considers the new knowledge and some hypotheses accumulated during the last few years regarding the aetiology of inflammatory bowel disease. The role of genetic susceptibility, in particular the first gene where a mutation is responsible for part of patients with Crohn's disease, is discussed. The consequence for phenotype variability and the environmental influences regarding manifestation of the disease are analysed by experts. Finally, alternative hypotheses including an immune deficiency and defective local bacterial response are demonstrated. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:585 / 586
页数:2
相关论文
共 50 条
  • [41] New insights into the molecular mechanisms of thalidomide in paediatric inflammatory bowel disease patients
    Lucafo, M.
    Bramuzzo, M.
    Pugnetti, L.
    Gerdol, M.
    Greco, S.
    Paci, M.
    Curci, D.
    Nonnis, M.
    Renzo, S.
    Lionetti, P.
    Tommasini, A.
    Decorti, G.
    Stocco, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S345 - S346
  • [42] Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
    Iliev, Iliyan D.
    Ananthakrishnan, Ashwin N.
    Guo, Chun-Jun
    NATURE REVIEWS MICROBIOLOGY, 2025,
  • [43] Recent developments on the role of Clostridium difficile in inflammatory bowel disease
    Hugh James Freeman
    World Journal of Gastroenterology, 2008, (18) : 2794 - 2796
  • [44] Inflammatory Bowel Disease ManagementSome Thoughts on Future Drug Developments
    John Rhodes
    Gareth Thomas
    Brian K. Evans
    Drugs, 1997, 53 : 189 - 194
  • [45] Irritable bowel syndrome - the new inflammatory bowel disease?
    Spiller, Robin
    CLINICAL MEDICINE, 2008, 8 (04) : 417 - 419
  • [46] Therapeutic drug monitoring in inflammatory bowel disease: recent developments
    Roblin, Xavier
    Little, Robert D.
    Mathieu, Nicolas
    Paul, Stephane
    Nancey, Stephane
    Barrau, Mathide
    Sparrow, Miles P.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (10) : 575 - 586
  • [47] Recent developments on the role of Clostridium difficile in inflammatory bowel disease
    Freeman, Hugh James
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (18) : 2794 - 2796
  • [48] Novel pharmacological developments in the management of paediatric inflammatory bowel disease
    Grover, Zubin
    Day, Andrew S.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2024, 60 (06) : 162 - 163
  • [49] Inflammatory bowel disease: A new assessment
    Gitnick, G
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 83 - 86
  • [50] New pharmaceuticals in inflammatory bowel disease
    Lodyga, Michal
    Eder, Piotr
    Bartnik, Witold
    Gonciarz, Maciej
    Klopocka, Maria
    Linke, Krzysztof
    Malecka-Panas, Ewa
    Radwan, Piotr
    Rydzewska, Grazyna
    PRZEGLAD GASTROENTEROLOGICZNY, 2015, 10 (02): : 57 - 60